Position in ALKS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,717,781
New position
Shares Held
90,034
first reported quarter
Ownership
0.054%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
#126
of 423 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Carrera Capital Advisors holds $7,397,468 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (63.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
90,034 | $4,717,781 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
167,167 | $2,679,687 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,717,781 | 90,034 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||